首页> 外文会议>The Second Asian symposium on pharmaceutical sciences and technology >Enhanced stability of insulin by liposomes containing sodium glycocholate in both simulated and endogenous gastrointestinal fluids
【24h】

Enhanced stability of insulin by liposomes containing sodium glycocholate in both simulated and endogenous gastrointestinal fluids

机译:在模拟和内源性胃肠液中,含糖胆酸钠的脂质体可增强胰岛素的稳定性

获取原文
获取原文并翻译 | 示例

摘要

Purposes: To illustrate the possible mechanism of enhanced oral absorption of insulin (INS) by liposomes containing sodium glycocholate (NaGC-Lip) through the stability evaluation in both simulated and endogenous gastrointestinal fluids.; Methods: The remained INS concentration from NaGC-Lip after incubation in simulated gastrointestinal fluids (SGF, FaSSGF, SIF and FeSSIF-V2) and rats' gastric and intestinal fluids was compared with that from conventional liposomes (CH-Lip).; Results: The remained INS concentration was significantly higher from NaGC-Lip than that from CH-Lip in all tested simulated and endogenous gastrointestinal fluids, which was mainly ascribed to the enzyme-inhibiting ability of sodium glycocholate.; Conclusion: The enhanced in vivo stability of INS from NaGC-Lip was advantageous to the oral delivery of INS.
机译:目的:通过模拟和内源性胃肠液中的稳定性评估,来说明含糖胆酸钠(NaGC-Lip)的脂质体增强胰岛素(INS)口服吸收的可能机制。方法:将NaGC-Lip在模拟胃肠道液(SGF,FaSSGF,SIF和FeSSIF-V2)以及大鼠的胃和肠液中孵育后的剩余INS浓度与常规脂质体(CH-Lip)进行比较。结果:在所有测试的模拟和内源性胃肠液中,NaGC-Lip的残留INS浓度均显着高于CH-Lip,这主要归因于甘露酸钠的酶抑制能力。结论:NaGC-Lip增强了INS的体内稳定性,有利于INS的口服给药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号